Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome

• Saskia M. Rombach,

  Affiliation Department of Endocrinology and Metabolism, Division of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Johannes M. F. G. Aerts,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Ben J. H. M. Poorthuis,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Johanna E. M. Groener,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Wilma Donker-Koopman,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Erik Hendriks,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Mina Mirzaian,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Sijmen Kuiper,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Frits A. Wijburg,

  Affiliation Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Carla E. M. Hollak,

  Affiliation Department of Endocrinology and Metabolism, Division of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

  ⨯
• Gabor E. Linthorst

  * E-mail: g.e.linthorst@amc.nl

  Affiliation Department of Endocrinology and Metabolism, Division of Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands

  ⨯